Company Overview and News

1
10 Stocks You Need to Banish Right Now | InvestorPlace

3h investorplace
While there’s only a modest degree of empirical evidence to support the whole “sell in May and go away” adage, this time around it might be wide advice to heed. The market remains unable to follow through on near-term bullish efforts, and despite a reasonably assuring beginning to the first quarter’s earnings season, traders have largely responded to those reports in a bearish manner.
Upvote Downvote

1
AMD: A Trade Strategy

3h seekingalpha
Here is how one can participate in upward movement of AMD without the immediate full capital risk of owning the stock.
Upvote Downvote

 
Wall Street ends mixed as investors eye earnings

18h thehindubusinessline
The Dow Jones Industrial Average fell 14.25 points, or 0.06 per cent, to 24,448.69, the S&P 500 gained 0.15 points, or 0.01 per cent, to 2,670.29 and the Nasdaq Composite dropped 17.53 points, or 0.25 per cent, to 7,128.60.
Upvote Downvote

 
Wall St ends mixed as investors eye earnings

18h moneycontrol
Wall Street ended mixed on Monday as concerns about soft smartphone demand weighed on tech stocks and pulled the Nasdaq lower while earnings optimism protected against deeper losses.
Upvote Downvote

 
Wall Street ends mixed as investors eye earnings

2018-04-23 channelnewsasia
U.S. stocks index futures treaded water on Monday, ahead of a bevy of earnings from the world's biggest companies and as wary investors watched U.S. bond yields approach peaks that have sparked stock selloffs in the past.
Upvote Downvote

 
Goldman Sachs, Procter & Gamble Hobble the Dow Monday

2018-04-23 247wallst
April 23, 2018: Markets opened higher Monday but after hanging around the break-even line for all morning and into the afternoon, equities finally slid lower and appear to be headed for a lower close. Sales of existing homes rose a bit and gasoline prices are rising quickly. 10-year Treaury yields are approaching 3% and that is attracting more investments in bonds.
Upvote Downvote

 
Wall Street edges lower as tech stocks, bond yields weigh

2018-04-23 channelnewsasia
U.S. stocks index futures treaded water on Monday, ahead of a bevy of earnings from the world's biggest companies and as wary investors watched U.S. bond yields approach peaks that have sparked stock selloffs in the past.
Upvote Downvote

1
3-Plus Customer-Facing 5G Stocks You Didn’t Know About

2018-04-23 investorplace
Most Americans who think of 5G providers will tend to think of AT&T Inc. (NYSE:T), Verizon Communications Inc. (NYSE:VZ), T-Mobile US Inc (NASDAQ:TMUS), and Sprint Corp (NYSE:S). These providers will provide most of the 5G service to American customers.
Upvote Downvote

 
AMD: Earnings Will Clear The Smoke

2018-04-23 seekingalpha
In the past months, AMD (AMD) unveiled Ryzen 3 mobile, Raven Ridge architecture and the second generation of Ryzen. Despite these unveilings, AMD is once again trading close to single digits.
Upvote Downvote

 
AMD: Here's Why You Shouldn't Ignore Zen+

2018-04-23 seekingalpha
As Zen+ outperforms Intel in mainstream games, it’s hard to see Intel defend its market share.
Upvote Downvote

 
Should You Buy the Dip in Chip ETFs Ahead of Q1 Earnings?

2018-04-23 zacks
The semiconductor corner of the broad technology market was badly hit last week amid a spate of negative news from industry players like chipmaker Taiwan Semiconductor Manufacturing TSM and semiconductor-equipment supplier Lam Research LRCX. Taiwan Semiconductor reduced its target for sales growth in the global semiconductor industry this year to 5% from its prior outlook of 5-7% growth while Lam Research offered a disappointing outlook for chip-gear shipments for the rest of the year.
Upvote Downvote

 
Q1 Earnings Deluge

2018-04-23 zacks
After a prolonged period of 10-year bond yields relatively stagnant in the 2.8s earlier this year — while equity markets were setting a wild roller coaster in motion — we now see the 10-year peek its head up near 3% for the first time since the end of 2013. At 2.966%, market participants are beginning to pay close attention here, with a ratcheted-up bond yield signifying things like increased economic inflation, which would likely prompt the Fed to raise interest rates higher, faster.
Upvote Downvote

 
Intel (INTC) to Report Q1 Earnings: What's in the Cards?

2018-04-23 zacks
Intel Corp (INTC - Free Report) is set to report first-quarter 2018 results on Apr 26. Notably, the company has a record of positive earnings surprises in the trailing four quarters, with an average beat of 14.81%. Last quarter, the company delivered a positive earnings surprise of 25.58%. Last quarter, revenues totaled $17.05 billion, reflecting an increase of 4.1% year over year and 5.6% sequentially.
Upvote Downvote

 
Q1 Earnings, 10-Year Yield Heating Up

2018-04-23 zacks
Monday, April 23, 2018 After a prolonged period of 10-year bond yields relatively stagnant in the 2.8s earlier this year — while equity markets were setting a wild roller coaster in motion — we now see the 10-year peek its head up near 3% for the first time since the end of 2013. At 2.966%, market participants are beginning to pay close attention here, with a ratcheted-up bond yield signifying things like increased economic inflation, which would likely prompt the Fed to raise interest rates higher, faster.
Upvote Downvote

 
Is a Beat in the Cards for Xilinx (XLNX) in Q4 Earnings?

2018-04-23 zacks
Xilinx Inc. (XLNX - Free Report) is scheduled to release fourth-quarter fiscal 2018 results on Apr 25. Notably, the stock has delivered an average positive earnings surprise of 9% in the trailing four quarters. In the last reported quarter, the company came up with a positive earnings surprise of 20.6%. The Zacks Consensus Estimate for fourth-quarter earnings is pegged at 68 cents per share, indicating a 19.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

CUSIP: 458140100